Accusure Insulin Syringes

Accusure Insulin Syringes (Qualitest Pharm) - Nationwide recall of all lots due to potential for needle to become detached from syringe


Accusure Insulin Syringes (Qualitest Pharmaceuticals) - Recall
Audience: Diabetes healthcare professionals and patients
Qualitest Pharmaceuticals and FDA notified healthcare professionals of a nationwide recall of Accusure Insulin Syringes. All syringes, regardless of lot number, are subject to this recall. These syringes were distributed between January 2002 and October 2009 to wholesale and retail pharmacies nationwide (including Puerto Rico). The syringes in these lots may have needles which detach from the syringe. If the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into to the syringe, or remain in the skin after injection. Consumers who have any Accusure insulin syringes should stop using them and contact Qualitest at 1-800-444-4011 for reimbursement.
Read the complete MedWatch 2009 Safety summary, including a link to the firm's press release and previous August 2009 recall, at:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm188151.htm

Accusure Insulin Syringes (Qualitest Pharmaceuticals) - Recall
Audience: Diabetes healthcare professionals and patients

[Posted 10/27/2009] Qualitest Pharmaceuticals and FDA notified healthcare professionals of a nationwide recall of Accusure Insulin Syringes. All syringes, regardless of lot number, are subject to this recall. These syringes were distributed between January 2002 and October 2009 to wholesale and retail pharmacies nationwide (including Puerto Rico). The syringes in these lots may have needles which detach from the syringe. If the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into to the syringe, or remain in the skin after injection. Consumers who have any Accusure insulin syringes should stop using them and contact Qualitest at 1-800-444-4011 for reimbursement.

[10/27/2009 - Press Release - Qualitest Pharmaceuticals]

Previous MedWatch Alert

[08/24/2009]